109 results on '"Fanaroff, Alexander C."'
Search Results
2. Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: Rationale and Design of the SUPER LIPID Program
3. Gamification-Augmented hoMe-based Exercise for Peripheral Artery Disease: Rationale and Design of the GAMEPAD Study
4. Chronic Coronary Disease
5. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
6. Abstract 17514: Changing Default Prescription Length to Reduce Barriers to Statin Adherence
7. Standing up for equitable treatment of coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries
8. Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality
9. High-Sensitivity Troponin in Patients With Cancer
10. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials
11. Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia
12. Feasibility and outcomes from using a commitment devices and text message reminders to increase adherence to time-restricted eating: A randomized trial
13. Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
14. A Randomized Controlled Trial of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients with Elevated Risk for Cardiovascular Disease: Rationale and Design of the BE ACTIVE Study
15. Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies
16. COVID-19 Thrombotic Complications and Therapeutic Strategies
17. Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute?
18. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
19. Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem
20. Seeking patient-centered trial outcomes: The case for days alive out of hospital
21. Independence of clinical events committees: A consensus statement from clinical research organizations
22. Recognising acute coronary syndrome
23. Percutaneous Coronary Intervention in Acute Coronary Syndrome and Cardiogenic Shock
24. EPIDEMIOLOGY AND OUTCOMES OF PATIENTS READMITTED TO THE INTENSIVE CARE UNIT AFTER CARDIAC INTENSIVE CARE UNIT ADMISSION
25. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
26. Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
27. Economic Considerations in Access to Transcatheter Aortic Valve Replacement
28. Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas
29. Rural-Urban Disparities in Cardiovascular Outcomes
30. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
31. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy
32. Myocardial Infarction During the COVID-19 Pandemic
33. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
34. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance
35. Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018
36. 1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
37. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population
38. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas
39. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
40. EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL
41. Adding Precision to Defining Bleeding and Ischemic Risk With PCI in Cancer Patients
42. Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry
43. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
44. Variability in Reported Percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
45. Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non–ST-Segment–Elevation Myocardial Infarction for Intensive Care Unit Admission
46. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair
47. Association between intensive care unit utilization for patients with non–ST-segment elevation myocardial infarction and patient experience
48. Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement
49. Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more?
50. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.